Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering

Core Viewpoint - Guardant Health, Inc. has announced the pricing of an upsized offering of $350.0 million in aggregate principal amount of 0% convertible senior notes due 2033, aimed at qualified institutional buyers under Rule 144A of the Securities Act [1] Group 1 - The offering consists of convertible senior notes, which are debt securities that can be converted into a predetermined number of the company's shares [1] - The notes are due in 2033, indicating a long-term financing strategy for the company [1] - The offering is classified as a private offering, targeting institutional investors rather than the general public [1]